Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination
Blood Cover Image for Volume 146, Issue 5
Current Issue
Volume 146,
Issue 5,
July 31 2025
View This Issue

Issue Highlights


Latest in Blood
Free Articles
Time-tested safety: FCARH143’s 5-year myeloma journey Free
Samer Al Hadidi
https://doi.org/10.1182/blood.2025029157
View All Free Articles
Plenary Papers
HNRNPC and m 6 A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia Available to Purchase
Jonas De Kesel; Igor Fijalkowski; Tim Pieters; Cristina Borin; Kasper Thorhauge Christensen; Manou Wittouck; Jolien Van Laere; Laura Guerrero; Lindy Reunes; Marino Caruso; Bijal Thakkar; Wouter Sleeckx; Luyao Kevin Xu; Filip Van Nieuwerburgh; Dieter Deforce; Kim De Keersmaecker; Tim Lammens; Steven Goossens; Tom Taghon; Cuijuan Han; Giulia Veltri; Valentina Serafin; Bruno Palhais; Nitesh D. Sharma; Hao Huang; Hudan Liu; Ksenia Matlawska-Wasowska; Ana Milovanovic; Eva Maria Novoa; Eric Wang; Panagiotis Ntziachristos
https://doi.org/10.1182/blood.2024026848
View All Plenary Papers
First Edition
New prognostic systems for multiple myeloma in the context of contemporary therapies Available to Purchase
Andrew Spencer
https://doi.org/10.1182/blood.2024023841
View All First Edition Articles
Clinical Trials and Observations
The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy Open Access
Naval Daver; Paresh Vyas; Gerwin Huls; Hartmut Döhner; Sébastien Maury; Jan Novak; Cristina Papayannidis; Carmen Martínez Chamorro; Pau Montesinos; Rabin Niroula; Pierre Fenaux; Jordi Esteve; Shang-Ju Wu; Adrien De Voeght; Jiri Mayer; Peter J. M. Valk; Lisa Johnson; Mei Dong; Ke Liu; Sowmya Kuwahara; Kenneth Caldwell; Guru Subramanian Guru Murthy
https://doi.org/10.1182/blood.2024027506
View All Clinical Trials and Observations

Advertisement intended for health care professionals

Over 165,000 citations
earned in 2024

ASH Commitment to Expansion and Inclusion in Hematology
Acknowledgement of Reviewers for 2024

Featured Content

A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up

Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of “Super” transplantability

Modeling the HLH immune synapse uncovers critical roles for IS termination, cytokine intensity, and target cell death

Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes

NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation

Magrolimab plus azacitidine vs physician’s choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals